Totals
- Total revenue
- $3,848,762
- Total expenses
- $3,196,702
- Contributions and grants received
- $0
- Grants paid
- $0
- Program service revenue
- $3,848,762
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $30,050,664
- Total liabilities, end of year
- $25,410,999
- Net assets or fund balances, end of year
- $4,639,665
- Program services expenses (Part IX)
- $3,196,702
- Management and general expenses
- $0
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $3,196,702
Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
2a · Program service revenue: MAY ST MEDICAL -RENTAL INCOME
total $2,426,963 · excluded $2,426,963
-
2b · Program service revenue: JIII - RENTAL INCOME
total $627,276 · excluded $627,276
-
2c · Program service revenue: OLYPHANT - RENTAL INCOME
total $509,103 · excluded $509,103
-
2d · Program service revenue: JESSUP - RENTAL INCOME
total $285,420 · excluded $285,420
Functional expenses
Part IX, the statement of functional expenses.
-
13 · Office expenses
total $2,457 · program services $2,457
-
16 · Occupancy
total $2,601,090 · program services $2,601,090
-
22 · Depreciation, depletion and amortization
total $592,263 · program services $592,263
-
24a · Other expenses: BANK CHARGES
total $892 · program services $892
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $327,272 · end of year $741,096
-
9 · Prepaid expenses and deferred charges
beginning of year $84,017 · end of year $188,892
-
10a · Land, buildings and equipment: cost or other basis
$35,970,589
-
10b · Land, buildings and equipment: accumulated depreciation
$10,306,568
-
10c · Land, buildings and equipment, net
beginning of year $13,095,977 · end of year $25,664,021
-
15 · Other assets
beginning of year $3,464,710 · end of year $3,456,655
-
17 · Accounts payable and accrued expenses
beginning of year $42,521 · end of year $87,955
-
23 · Secured mortgages and notes payable
beginning of year $4,570,352 · end of year $14,265,494
-
25 · Other liabilities
beginning of year $8,371,498 · end of year $11,057,550
-
27 · Net assets without donor restrictions
beginning of year $3,987,605 · end of year $4,639,665
Mission and programs · 2023
Mission
BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF) A NON-PROFIT 501(C) ORGANIZATION AND DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH, (DIZG) A GERMAN NON-PROFIT ORGANIZATION (AS DISCLOSED ON FORM 5471). MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIO, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIO ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIO CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOG
Activities or mission (Part I)
BIOCON, INC'S. (BIO) MISSION IS TO SUPPORT THE TAX-EXEMPT MISSION OF THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF). CONTINUED ON SCHEDULE O.
-
SEE SCHEDULE O.
Expenses $3,196,702
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Joseph A YaccarinoJOSEPH A YACCARINO
PRESIDENT/CE
- Total calculated
- $914,560
- From this org
- $0
- From related orgs
- $863,875
- Other
- $50,685
Schedule J breakdown matched by us
- Base
- not reported + $659,467 related
- Bonus
- not reported + $191,580 related
- Other
- not reported + $12,828 related
- Deferred
- not reported + $19,800 related
- Nontaxable benefits
- not reported + $33,930 related
- Filer's total
- not reported + $914,560 related
-
Michael J KawasMICHAEL J KAWAS
TREASURER/CF
- Total calculated
- $707,128
- From this org
- $0
- From related orgs
- $673,909
- Other
- $33,219
Schedule J breakdown matched by us
- Base
- not reported + $545,316 related
- Bonus
- not reported + $120,820 related
- Other
- not reported + $7,773 related
- Deferred
- not reported + $19,800 related
- Nontaxable benefits
- not reported + $16,464 related
- Filer's total
- not reported + $707,128 related
-
Jennifer BirminghamJENNIFER BIRMINGHAM
SECRETARY/GE
- Total calculated
- $538,363
- From this org
- $0
- From related orgs
- $487,128
- Other
- $51,235
Schedule J breakdown matched by us
- Base
- not reported + $395,200 related
- Bonus
- not reported + $90,410 related
- Other
- not reported + $1,518 related
- Deferred
- not reported + $19,800 related
- Nontaxable benefits
- not reported + $34,480 related
- Filer's total
- not reported + $538,363 related
-
William W Tomford MDWILLIAM W TOMFORD MD
DIRECTOR
- Total calculated
- $75,000
- From this org
- $0
- From related orgs
- $75,000
- Other
- $0
-
Donald Hackbarth MDDONALD HACKBARTH MD
DIRECTOR
- Total calculated
- $35,000
- From this org
- $0
- From related orgs
- $35,000
- Other
- $0
-
Joseph Zuckerman MDJOSEPH ZUCKERMAN MD
DIRECTOR
- Total calculated
- $30,000
- From this org
- $0
- From related orgs
- $30,000
- Other
- $0
-
Symeria T HudsonSYMERIA T HUDSON
DIRECTOR
- Total calculated
- $28,750
- From this org
- $0
- From related orgs
- $28,750
- Other
- $0
-
Joseph A Buckwalter MDJOSEPH A BUCKWALTER MD
DIRECTOR
- Total calculated
- $27,500
- From this org
- $0
- From related orgs
- $27,500
- Other
- $0
-
Sharon GabrielsonSHARON GABRIELSON
DIRECTOR
- Total calculated
- $25,000
- From this org
- $0
- From related orgs
- $25,000
- Other
- $0
-
Allan Gross MDALLAN GROSS MD
NON-VOTING D
- Total calculated
- $0
-
Gerald Finerman MDGERALD FINERMAN MD
NON-VOTING D
- Total calculated
- $0
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- SCHEDULE J, PAGE 1, PART I, LINE 3
- BIOCON, INC., (BIO), IS THE SOLE CORPORATE MEMBER OF THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., (MTF). THE BOARD OF DIRECTORS AND THE OFFICERS OF BIO OVERLAPS THAT OF MTF WITH BIO HAVING THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF. BELOW IS AN OUTLINE OF MTF'S PROCESS TO ESTABLISH COMPENSATION LEVELS FOR EXECUTIVE AND OFFICER COMPENSATION. EACH YEAR, MTF RECEIVES AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR THE EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN JULY 2023, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY JULY 2023), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW: MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
MUSCULOSKELETAL TRANSPLANT FOUNDATION INC
501C3 · TISSUE BK. · DC · controlled entity
Directly controlled by BIOCON
-
DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH
SEE PT VII · GM · controlled entity
Directly controlled by BIOCON
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
MAY STREET MEDICAL LLC
SEE PT VII · DE · income $2,426,963 · assets $10,602,573
Directly controlled by BIOCON
-
SEE PT VII · DE · income $509,103 · assets $3,226,818
Directly controlled by BIOCON
-
SEE PT VII · PA · income $285,420 · assets $2,175,005
Directly controlled by BIOCON
-
SEE PT VII · PA · income $627,276 · assets $14,035,922
Directly controlled by BIOCON
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH
C CORP · SEE PT VII · GM
Directly controlled by BIOCON
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 15 November 2024
- IRS schema version
- 2023v5.0
- Source object
- 202433209349313818
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.